Vaccine-resistant malaria

New England Journal of Medicine

Volumn 373, Issue 21, 2015, Pages 2082-2083

  Plowe, Christopher V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; DNA EXTRACTION; DRUG EFFICACY; EDITORIAL; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MALARIA; NEXT GENERATION SEQUENCING; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; VACCINE PRODUCTION; FEMALE; GENETICS; IMMUNOLOGY; MALARIA, FALCIPARUM; MALE;

FEMALE; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM;

EID: 84947731081     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1511955     Document Type: Editorial

References (10)

1. Salk JE. Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. JAMA 1953;151:1081-98.
2. Genton B, Betuela I, Felger I, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002; 185: 820-7.
3. Thera MA, Doumbo OK, Coulibaly D, et al. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 2011; 365: 1004-13.
4. Enosse S, Dobaño C, Quelhas D, et al. RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials 2006; 1(1): e5.
5. Waitumbi JN, Anyona SB, Hunja CW, et al. Impact of RTS, S/AS02(A) and RTS, S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS One 2009;4(11):e7849.
6. Gandhi K, Thera MA, Coulibaly D, et al. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications. PLoS One 2014; 9(7): e101783.
7. Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria.' Parasite Immunol 2009; 31: 560-73.
8. Neafsey DE, Juraska M, Bedford T, et al. Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine. N Engl J Med 2015;373:2025-37.
9. Ouattara A, Takala-Harrison S, Thera MA, et al. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J Infect Dis 2013; 207: 511-9.
10. Heppner DG Jr, Kester KE, Ockenhouse CF, et al. Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falci-parum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 2005;23:2243-50.